Breast Atypical Hyperplasia
3 clinical trials · Condition
◉ Watch Breast Atypical Hyperplasia
| Record | Firm | Date |
|---|---|---|
| Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction (NCT06195306) | National Cancer Institute (NCI) | 2025-07-28 |
| Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer (NCT05941520) | National Cancer Institute (NCI) | 2024-10-10 |
| Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk (NCT04570956) | Mayo Clinic | 2021-07-26 |
Track Breast Atypical Hyperplasia automatically
Every clearance here is in the API, with alerts when new ones post.